Silencing of the hTERT gene through RNA interference induces apoptosis via Bax/Bcl-2 in human glioma cells

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1153-1158

  Wang, Tuo ^a   Xue, Yan ^a   Wang, Maode ^a   Sun, Qiang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Glioma; hTERT; Telomerase

Indexed keywords

MESSENGER RNA; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TELOMERASE REVERSE TRANSCRIPTASE GENE; IN VIVO GENE TRANSFER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN NEOPLASMS; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GLIOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; TELOMERASE;

EID: 84866456626     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1952     Document Type: Article

References (28)

1. Lino MM and Merlo A: PI3Kinase signaling in glioblastoma. J Neurooncol 103: 417-427, 2011.
2. Zhao P, Wang C, Fu Z, et al: Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner. Int J Oncol 31: 361-368, 2007.
3. Li C, Zhou C, Wang S, et al: Sensitization of glioma cells to tamoxifen-induced apoptosis by Pl3-kinase inhibitor through the GSK-3beta/beta-catenin signaling pathway. PLoS One 6: e27053, 2011.
4. Prados MD and Levin V: Biology and treatment of malignant glioma. Semin Oncol 27: 1-10, 2000. (Pubitemid 30390229)
5. Ponnala S, Chetty C, Veeravalli KK, Dinh DH, Klopfenstein JD and Rao JS: MMP-9 silencing regulates hTERT expression via beta1 integrin-mediated FAK signaling and induces senescence in glioma xenograft cells. Cell Signal 23: 2065-2075, 2011.
6. Shervington A, Cruickshanks N, Wright H, et al: Glioma: what is the role of c-Myc, hsp90 and telomerase? Mol Cell Biochem 283: 1-9, 2006.
7. Feng J, Funk WD, Wang SS, et al: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
8. Harrington L, McPhail T, Mar V, et al: A mammalian telomerase-associated protein. Science 275: 973-977, 1997. (Pubitemid 27087712)
9. Nakayama JI, Saito M, Nakamura H, Matsuura A and Ishikawa F: TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875-884, 1997. (Pubitemid 27164275)
10. Meyerson M, Counter CM, Eaton EN, et al: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997. (Pubitemid 27357969)
11. Kondo S, Kanzawa T, Germano IM, Kondo Y, Ito H and Kyo S: Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. Br J Cancer 89: 922-929, 2003. (Pubitemid 37175817)
12. Ferguson SD: Malignant gliomas: diagnosis and treatment. Dis Mon 57: 558-569, 2011.
13. Furnari FB, Fenton T, Bachoo RM, et al: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007. (Pubitemid 350070717)
14. Adams JM and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337, 2007. (Pubitemid 46328466)
15. Xue Y, Li L, Zhang D, et al: Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth. Oncol Rep 24: 1551-1559, 2010.
16. Zhang Y, Cheng Y, Zhang L, et al: Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression. Biochem Biophys Res Commun 414: 129-134, 2011.
17. George J, Banik NL and Ray SK: Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines. Int J Biochem Cell Biol 42: 1164-1173, 2010.
18. Shammas MA, Koley H, Batchu RB, et al: Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4: 24, 2005.
19. Chen CH and Chen RJ: Prevalence of telomerase activity in human cancer. J Formos Med Assoc 110: 275-289, 2011.
20. Shay JW and Wright WE: Role of telomeres and telomerase in cancer. Semin Cancer Biol 21: 349-353, 2011.
21. George J, Banik NL and Ray SK: Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res 15: 7186-7195, 2009.
22. Wang YF, Wang DL, Shi GS and Huang H: Expressions of hTERT, HIF-1alpha and CD105 in gliomas and their clinical significance. Zhonghua Bing Li Xue Za Zhi 35: 681-682, 2006 (In Chinese).
23. Packham G and Cleveland JL: c-Myc and apoptosis. Biochim Biophys Acta 1242: 11-28, 1995.
24. Lutz W, Leon J and Eilers M: Contributions of Myc to tumorigenesis. Biochim Biophys Acta 1602: 61-71, 2002. (Pubitemid 34311900)
25. von Bueren AO, Shalaby T, Oehler-Janne C, et al: RNA interference- mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer 9: 10, 2009.
26. Louis DN: The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 53: 11-21, 1994.
27. Levine AJ, Hu W and Feng Z: The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036, 2006.
28. Krakstad C and Chekenya M: Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9: 135, 2010.